EUVIMEDEUVIMED entdecken
Crossref

Predicting Treatment Quality in Children and Adolescents with Congenital Adrenal Hyperplasia Using Insulin and Renin

Eva Ammann, Philipp E Augsburger, Ozair Abawi, Suzanne E Smit, Sabine E Hannema, Christiaan de Bruin iD, Evangelia Charmandari iD, Erica L T van den Akker, Roland A Ammann, Christa E Flück iD

European Journal of Endocrinology · 16.11.2026

DOI: 10.1093/ejendo/lvag208 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Endocrinology, online erschienen am 16.11.2026. Verfasst von Eva Ammann und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Endocrinology, Diabetology and Metabolism, Department of Pediatrics, Bern.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Monitoring treatment quality in congenital adrenal hyperplasia (CAH) remains challenging. Current approaches rely predominantly on bone age and serum steroid measurements, which are variable and require expert interpretation. Reliable, accessible biochemical indicators are lacking.

Objective

To develop and evaluate a predictive score for undertreatment in children and adolescents with CAH using routinely available clinical and non-steroid laboratory parameters.

Methods

We conducted a prospective, multicenter cohort study including 81 patients with genetically confirmed 21-hydroxylase deficiency across four European pediatric endocrinology centers. Clinical features and laboratory parameters—including fasting insulin, renin, lipid profile, glucose, and growth indices—were assessed at three outpatient visits. Treatment status (optimal, undertreatment, overtreatment) was classified by expert endocrinologists. Logistic regression analyses were performed to identify predictors of undertreatment and to construct a predictive model.

Results

Data from 233 visits were analyzed. Undertreated patients showed significantly higher insulin (p = 0.005), higher renin (p = 0.003), increased height SDS (p = 0.014), and lower HDL cholesterol (p = 0.007) compared with optimally treated patients. The final predictive model retained insulin (coefficient 1.15) and renin (1.038) as independent predictors. At a threshold of ≥30–36, sensitivity was 71%, specificity 84%and overall correct classification 80%. The ROC curve yielded an AUC of 0.785.

Conclusion

Serum insulin and renin, two inexpensive and routinely measured parameters, predict undertreatment in children and adolescents with CAH with good accuracy. Their dual relevance for short-term treatment monitoring and long-term cardiometabolic risk underscores their potential as practical tools to complement current strategies.

Schlagwörter

Stichwörter der Autor:innen

21-Hydroxylase deficiencyCAHHDL-cholesterolcongenital adrenal hyperplasiainsulinrenintreatment monitoring

Autor:innen und Institutionen

  • Division of Pediatric Endocrinology, Diabetology and Metabolism, Department of Pediatrics, Bern.
  • University Hospital Inselspital, University of Bern, Bern 3010, Switzerland.
  • Department for Biomedical Research, University Hospital Inselspital, University of Bern, Bern 3008, Switzerland.
  • Graduate School for Cellular and Biomedical Sciences, University of Bern, 3008 Bern, Switzerland.
  • Division of Pediatric Endocrinology, Department of Pediatrics, Erasmus University Medical Centre, Sophia Children's Hospital, 3015 GD Rotterdam, the Netherlands.
  • Division of Endocrinology, Department of Pediatrics, Willem-Alexander Children's Hospital, Leiden University Medical Center, Leiden 2333 ZA, The Netherlands.

ORCID-Profile: Christiaan de Bruin, Evangelia Charmandari, Christa E Flück

Zitieren

APA

Ammann, E., Augsburger, P. E., Abawi, O., Smit, S. E., Hannema, S. E., de Bruin, C., Charmandari, E., van den Akker, E. L. T., Ammann, R. A., & Flück, C. E. (2026). Predicting Treatment Quality in Children and Adolescents with Congenital Adrenal Hyperplasia Using Insulin and Renin. European Journal of Endocrinology. https://doi.org/10.1093/ejendo/lvag208

Vancouver

Ammann E, Augsburger PE, Abawi O, Smit SE, Hannema SE, de Bruin C, et al. Predicting Treatment Quality in Children and Adolescents with Congenital Adrenal Hyperplasia Using Insulin and Renin. European Journal of Endocrinology. 2026. doi:10.1093/ejendo/lvag208

BibTeX
@article{Ammann2026,
  author = {Ammann, Eva and Augsburger, Philipp E and Abawi, Ozair and Smit, Suzanne E and Hannema, Sabine E and de Bruin, Christiaan and Charmandari, Evangelia and van den Akker, Erica L T and Ammann, Roland A and Flück, Christa E},
  title = {Predicting Treatment Quality in Children and Adolescents with Congenital Adrenal Hyperplasia Using Insulin and Renin},
  journal = {European Journal of Endocrinology},
  year = {2026},
  doi = {10.1093/ejendo/lvag208}
}
Kostenlos starten →